Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novavax

7.29
-0.1800-2.41%
Volume:306.03K
Turnover:2.26M
Market Cap:1.17B
PE:-5.92
High:7.49
Open:7.49
Low:7.27
Close:7.47
Loading ...

FACTBOX-Pending US vaccine decisions as Kennedy takes top health job

Reuters
·
14 Feb

Novavax Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
12 Feb

Bank of America Securities Sticks to Its Hold Rating for Novavax (NVAX)

TIPRANKS
·
11 Feb

Novavax (NVAX) Outperforms Broader Market: What You Need to Know

Zacks
·
11 Feb

Novavax Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
08 Feb

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
06 Feb

Novavax (NVAX) Rises But Trails Market: What Investors Should Know

Zacks
·
05 Feb

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

Dow Jones
·
05 Feb

BUZZ-Vaccine makers fall as Kennedy moves closer to health secretary job

Reuters
·
05 Feb

Moderna Shares Down 4.4%, Pfizer Down 2%, Novavax Down Nearly 1%; US-Listed Shares of BioNTech Fall 2.6%

THOMSON REUTERS
·
04 Feb

Shares of Vaccine and Drug Manufacturers Fall as Senate Panel Backs Trump Health Secretary Nominee Robert F. Kennedy Jr.

THOMSON REUTERS
·
04 Feb

Novavax, Inc. (NASDAQ:NVAX) About To Shift From Loss To Profit

Simply Wall St.
·
04 Feb

Novavax Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
04 Feb

Novavax Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
01 Feb

New Strong Buy Stocks for January 30th

Zacks
·
30 Jan

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
29 Jan

Novavax (NASDAQ:NVAX) delivers shareholders strong 122% return over 1 year, surging 11% in the last week alone

Simply Wall St.
·
28 Jan

New Strong Buy Stocks for January 28th

Zacks
·
28 Jan

Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know

Zacks
·
28 Jan

Novavax Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
28 Jan